Insider Filings
Forms 3, 4 & 5
| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 04, 2021 |
Director
Trans History: 34
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 411 | $212.70 | 1,514 |
| Jan 04, 2021 |
Director
Trans History: 134
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 429 | $212.70 | 15,523 |
| Jan 04, 2021 |
Director
Trans History: 83
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 282 | $212.70 | 25,834 |
| Jan 04, 2021 |
Director
Trans History: 87
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 282 | $212.70 | 6,788 |
| Jan 04, 2021 |
Director
Trans History: 16
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 346 | $212.70 | 1,243 |
| Jan 04, 2021 |
Director
Trans History: 72
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 282 | $212.70 | 13,098 |
| Jan 04, 2021 |
Director
Trans History: 91
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 417 | $212.70 | 9,100 |
| Nov 11, 2022 |
SrVP and General Counsel
Trans History: 129
|
SrVP and General Counsel | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 18,482 | $212.62 | 49,463 |
| Oct 01, 2021 |
Director
Trans History: 91
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 135 | $212.28 | 9,617 |
| Nov 08, 2022 |
Director, Chairman and CEO
Trans History: 214
|
Director, Chairman and CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 40,520 | $211.20 | 170,881 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.